Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil G Docherty

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Scientific Reports|September 10, 2020
Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and deathWilliam P Martin, Colm Tuohy, Alison Doody, et al.
Journal of Diabetes and Its Complications|November 11, 2017
Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetesAlison Doody, Sabrina Jackson, Jessie A Elliott, et al.
Gut|November 23, 2019
Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie dietVille Wallenius, Erik Elias, Erik Elebring, et al.
Annals of Clinical Biochemistry|August 25, 2016
Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypassNegar Maghsoodi, Jamshid Alaghband-Zadeh, Gemma F Cross, et al.
Biochimica Et Biophysica Acta|April 10, 2013
IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responsesJames B Corcoran, Sarah McCarthy, Brenda Griffin, et al.
BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.
Journal of the American Society of Nephrology : JASN|May 30, 2008
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosisMadeline Murphy, Neil G Docherty, Brenda Griffin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2020
A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After EsophagectomyConor F Murphy, Nicholas Stratford, Neil G Docherty, et al.
Frontiers in Endocrinology|February 28, 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseWilliam P Martin, Yeong H D Chuah, Mahmoud Abdelaal, et al.
Clinical Obesity|August 27, 2020
Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centreWilliam P Martin, Jessica Bauer, John Coleman, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Scientific Reports|September 10, 2020
Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and deathWilliam P Martin, Colm Tuohy, Alison Doody, et al.
Journal of Diabetes and Its Complications|November 11, 2017
Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetesAlison Doody, Sabrina Jackson, Jessie A Elliott, et al.
Gut|November 23, 2019
Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie dietVille Wallenius, Erik Elias, Erik Elebring, et al.
Annals of Clinical Biochemistry|August 25, 2016
Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypassNegar Maghsoodi, Jamshid Alaghband-Zadeh, Gemma F Cross, et al.
Biochimica Et Biophysica Acta|April 10, 2013
IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responsesJames B Corcoran, Sarah McCarthy, Brenda Griffin, et al.
BMJ Open Diabetes Research & Care|August 5, 2020
Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney diseaseMeera Nair, William P Martin, Vadim Zhernovkov, et al.
Journal of the American Society of Nephrology : JASN|May 30, 2008
IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosisMadeline Murphy, Neil G Docherty, Brenda Griffin, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2020
A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After EsophagectomyConor F Murphy, Nicholas Stratford, Neil G Docherty, et al.
Frontiers in Endocrinology|February 28, 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney DiseaseWilliam P Martin, Yeong H D Chuah, Mahmoud Abdelaal, et al.
Clinical Obesity|August 27, 2020
Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centreWilliam P Martin, Jessica Bauer, John Coleman, et al.
Pageof 10